Wandering around in OHS’s databases – lots to learn and a surprise

Our state Office of Health Strategy has several impressive portals and dashboards to explore their trove of data and other information. They include healthcare affordability, ED visits, quality ratings, facility plans, self-sufficiency tools, hospital finances, prescription drug costs, and Race, ethnicity and language data. Visitors can sort the data by service, payer, age, gender, and…

Read More

ICER’s 4th annual report finds progress in fair access to prescription drugs

Over the last four years, barriers facing patients getting access to cost effective drugs in commercial plans and the Veteran’s Administration have gotten better, according to ICER’s fourth annual Barriers to Fair Access report. The authors compare plan policies, including cost sharing, clinical eligibility, step therapy and provider restrictions, to independent standards for fair access…

Read More

Report finds growing number of drug prices rising without merit

Half of the ten fastest-rising drug prices without any evidence of improved value last year, according to the latest report from ICER. This is the highest percentage of  unsupported prescription drug prices since ICER began this report in 2019. The increased prices rose far faster than inflation for the rest of the economy. Just the…

Read More

More questions and answers on DSS’s plan for HUSKY maternity bundles

Read the new questions and answers DSS is planning to move Medicaid payments for maternity services from the current fee-for-service arrangement to a per-person bundled payment. They will also expand services to include doula and lactation supports. However, advocates have asked questions and raised concerns about unintended consequences when providers make more money by reducing…

Read More

Materials from webinar on improved HUSKY cancer survival in CT without MCOs

Yesterday, Dr. John Cramer described his study published earlier this year describing a significant increase in cancer survival and early detection in Connecticut’s Medicaid program when the Managed Care Organizations left in 2012. Click here for slides and here for a recording of the webinar. The study — Association of Medicaid Privatization With Patient Cancer…

Read More

Analysis: DSS Study Suggests MCOs don’t Make Sense for HUSKY

Last Friday, the state released a consultants’ report exploring the Governor’s controversial plan to bring private insurers back to run Medicaid in Connecticut. The report’s authors agree with advocates that there is no evidence that MCOs control costs or improve quality or access to care. They also agree that HUSKY, our state Medicaid program, is…

Read More

Webinar: Study finds improved early cancer diagnosis and survival after MCOs left HUSKY

Join Rep. Jillian Gilchrest and Sen. Saud Anwar, Co-Chairs of MAPOC, for a webinar December 10th at 2pm with Dr. John Cramer on his study published in JCO Oncology Practice in January. His study found that cancer early detection have increased 4% and survival rates have increased 8% since MCOs left Connecticut Medicaid. There was…

Read More

Former Medicaid Official shares troubled MCO history

Download the comments In comments to DSS for their landscape study, former Medicaid official Steve Colangelo warns against returning the program to MCOs. He worked in the program before and after the MCOs left in 2012. He outlines the problems that plagued the program and DSS staff under the MCO model.  He details how the…

Read More

Analysis: How Trump’s Election Could Impact Healthcare in Connecticut

Health policy circles are buzzing with potential policy changes under the second Trump administration. Last time, Trump proposed significant cuts and administrative burdens for Medicaid, which covers 934,043 low-income Connecticut residents. That makes this a very bad time to be considering bringing the failed private Managed Care Organizations (MCOs) back into the program. Other significant…

Read More